News

2025 is a special year for us: we’re celebrating a decade of work, passion and growth at our plant in Klagenfurt, Austria, and at our office in Lyon, France. Two different stories united by the same energy and the same mission: making life easier and more enjoyable for people with special nutritional needs.

For those living with celiac disease, eating gluten-free isn’t a choice – it’s a daily necessity. But all too often, it can mean that something has to be sacrificed – taste, variety or nutritional balance.

At Dr. Schär, we believe that no-one should have to make this compromise. That’s why we’ve developed our Quality Commitment – a document that translates our values into concrete actions, with the aim to create nutritionally balanced and tastier Schär gluten-free products.

IBS is notably complex to manage and successful control of digestive symptoms requires a personalized approach. As part of our work with the GI Consortium, a collaboration of leading brands in the IBS space, we conducted a survey of patients and healthcare providers to understand the challenges both groups face around IBS treatment and management and to shed light on unmet patient and provider needs. Findings revealed areas where those with IBS can benefit from additional support and helped uncover areas where more robust resources for healthcare providers could improve patient care.

Under the leadership of our CEO Hannes Berger, Dr. Schär ended 2024 with an outstanding result: our global turnover reached USD 676 million, an increase of 11% compared to the previous year. This achievement is the result of a successful strategy and a clear vision, which allow us to continue to grow, shaping the future of gluten-free and special nutrition and responding even more closely to the needs of our consumers worldwide.

Pregnancy is an incredible journey, but for women with celiac disease it is still an ongoing challenge. Properly managing a nutritionally balanced and strict gluten-free diet during the journey to motherhood continues to be a difficult task. Current guidelines [1] do not provide recommendations for determining the appropriate energy intake for celiac women during pregnancy.

1.800 employees, spread across 18 sites in 12 different countries worldwide, 43% women, 4 generations in ongoing collaborative dialogue. Distinctive characteristics: using their skills, ability to work as a team and passion for their work to make a difference, improving the lives of people with special nutritional needs. This is the picture of our company population, a community of which we are proud and for which we are committed to a healthy and fair working environment.

The gluten-free diet is considered the gold standard and the only effective treatment for celiac disease. When followed correctly, it reduces inflammation and promotes gut healing, minimizing the risk of associated comorbidities such as bone density loss, vitamin and mineral deficiencies, the development of other autoimmune diseases, subfertility in both men and women, neurological complications, and the risk of small bowel cancer.

It does, however, still fall victim to stigma, which may contribute to low adherence to treatment.

Dr. Schär SPA Chairman, Ulrich Ladurner, has announced that Hannes Berger is the new CEO of the world leading company in specialised and gluten-free nutrition. Hannes Berger has held key positions in the Company for almost twenty years and has been a member of the Board of Directors since it was introduced. Hannes began his new role in January 2023, replacing former CEO Phillip Schoeller.

Gluten-free products are a matter of trust. They need to be safe because they represent the only treatment for those suffering from gluten-related disorders. They also need to be tasty because mealtimes should not be unpleasant experiences.